Primary cause of death of FinnDiane study participants stratified according to UAE and estimated GFR
n | Primary cause of death | All cause[n (% cohort)] | ||||
---|---|---|---|---|---|---|
Cardiovascular | Cancer | Infection | Other causes | |||
UAE | ||||||
Normoalbuminuria | 2,296 | 14 (47) | 2 (7) | 2 (7) | 12 (40) | 30 (1.3) |
Microalbuminuria | 504 | 15 (56)* | 1 (4) | 3 (11)* | 7 (30)* | 26 (5.2)* |
Macroalbuminuria | 578 | 40 (45)* | 3 (3)* | 18 (20)* | 28 (31)* | 89 (15.4)* |
ESKD | 293 | 78 (58)* | 7 (5)* | 24 (18)* | 26 (19)* | 135 (46.1)* |
Estimated GFR | ||||||
>120 | 272 | 5 (42) | 1 (8) | 1 (8) | 5 (42) | 12 (4.4)† |
60–120 | 2,699 | 28 (46) | 3 (5) | 8 (13) | 22 (36) | 61 (2.3) |
<60 | 462 | 42 (51)† | 3 (4)† | 15 (18)† | 22 (27)† | 82 (17.7)† |
ESKD | 293 | 78 (58)† | 7 (5)† | 24 (18)† | 26 (19)† | 135 (46.1)† |
Data are n (% deaths), unless otherwise noted.
*P value <0.05 vs. patients with normoalbuminuria <0.05, calculated by χ2;
†P value <0.05 vs. patients with an estimated GFR 60–120 ml/min per 1.73 m2, as calculated by χ2. ESKD, end-stage kidney disease.